KineMed has tapped Patrick Doyle to be executive VP and chief business officer. In the post, he will head corporate development activities, including licensing and strategic partnerships. Doyle previously was VP of strategic partnerships at PPD, president of Kareus Therapeutics, CEO of Syntaxin, and he held senior positions at F. Hoffman-La-Roche and Novo Nordisk.


Agilent this week named Dominique Grau as senior vice president of human resources. Grau will succeed Jean Halloran, who plans to retire at the end of the company's fiscal year, Oct. 31.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.